PROOPIOMELANOCORTIN (POMC) DISREGULATION AND RESPONSE TO OPIATE BLOCKERS
Guardat en:
SANDMAN, C.A., ET AL., PROOPIOMELANOCORTIN (POMC) DISREGULATION AND RESPONSE TO OPIATE BLOCKERS. MENTAL RETARDATION AND DEVELOPMENTAL DISABILITIES RESEARCH REVIEWS, Vol. 5, no. 4 (1999), p. 314-321.
Ref.
83245
Localització:
SIIS R.1376
Palabras clave:
Autismo, Discapacidad del lenguaje, Discapacidad intelectual, Efectos, Fármacos, Trastornos del espectro autista, Tratamiento
Autismo, Discapacidad del lenguaje, Discapacidad intelectual, Efectos, Fármacos, Trastornos del espectro autista, Tratamiento
Ítems similars: PROOPIOMELANOCORTIN (POMC) DISREGULATION AND RESPONSE TO OPIATE BLOCKERS
- DISSOCIATION OF POMC PEPTIDES AFTER SELF-INJURY PREDICTS RESPONSES TO CENTRALLY ACTING OPIATE BLOCKERS
- AN ORALLY ADMINISTERED OPIATE BLOCKER, NALTREXONE, ATTENUATES SELF-INJURIOUS BEHAVIOR
- BRIEF REPORT: OPEN TRIAL EFFECTS OF BETA-BLOCKERS ON SPEECH AND SOCIAL BEHAVIORS IN 8 AUTISTIC ADULTS
- ENDOGENOUS OPIOIDS AND OPIATE ANTAGONISTS IN AUTISM: BRIEF REVIEW OF EMPIRICAL FINDINGS AND IMPLICATIONS FOR CLINICIANS
- DIFFERENTIAL RESPONSE OF SEVEN SUBJECTS WITH AUTISTIC DISORDER TO CLOMIPRAMINE AND DESIPRAMINE
- FENFLURAMINE TREATMENT OF AUTISM: RELATIONSHIP OF TREATMENT RESPONSE TO BLOOD LEVELS OF FENFLURAMINE AND NONFENFLURAMINE